Target Diseases List that can be Potentially Cured by Undergoing the Kintaro Stem Cells® Therapy / Treatment Program

Allogeneic BM-MSCs like KINTARO STEM CELLS® are being researched in clinical trials around the world. They have the Potential to Treat over 100 Diseases, as shown in the table below, sources collected from ClinicalTrials.gov

 

#

Disease 疾患

Trial Name

Source

1

Liver Failure

肝不全

 

Allogeneic Bone Marrow Mesenchymal Stem Cells Transplantation in Patients With Liver Failure Caused by Hepatitis B Virus

 

Sun Yat-sen University, Taiwan

 

ClinicalTrials.gov Identifier:

NCT01322906

 

2

Acute Respiratory Distress Syndrome

 

急性呼吸窮迫症候群

Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)

Michael A. Matthay, University of California, San Francisco

 

ClinicalTrials.gov Identifier:

NCT01775774

 

3

Parkinson's Disease

 

パーキンソン病

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease

Mya Schiess, The University of Texas Health Science Center, Houston

 

ClinicalTrials.gov Identifier:

NCT02611167

 

4

Bi-polar Depression

 

双極性うつ病

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression

Jair Soares, The University of Texas Health Science Center, Houston

 

ClinicalTrials.gov Identifier:

NCT03522545

 

5

Crohn’s Disease

 

クローン病

Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease

HeinVerspaget, Leiden University Medical Center

 

ClinicalTrials.gov Identifier:

NCT01144962

 

6

Interstitial Lung

Disease

 

 

間質性肺疾患

Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease

Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

 

ClinicalTrials.gov Identifier:

NCT02594839

 

7

Osteodysplasia

 

骨異形成症

Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation

St. Jude Children's Research Hospital Memphis, Tennessee, United States

 

ClinicalTrials.gov Identifier:

NCT00186914

 

8

GVHD

 

 

移植片対宿主病

Allogeneic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

Armed Forces Bone Marrow Transplant Centre Rawalpindi, Punjab, Pakistan

 

ClinicalTrials.gov Identifier:

NCT02824653

 

9

Type 1 Diabetes Mellitus

 

1型糖尿病

MSC Administration for the Management of Type 1 Diabetic Patients (DMT1-MSC)

Clinica Alemana de Santiago Santiago, Region Metropolitana, Chile

 

ClinicalTrials.gov Identifier: NCT02893306

 

10

Arterial Disease

Vascular Disease

 

動脈疾患

血管疾患

A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation

Indiana University Indianapolis, Indiana, United States

 

ClinicalTrials.gov Identifier:

NCT02685098

 

11

Lupus

 

 

ループス病

Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)

Department of Rheumatology and Immunology, Nanjing University Medical College Affiliated Drum Tower Hospital Nanjing, Jiangsu, China

 

ClinicalTrials.gov Identifier:

NCT00698191

 

12

Sepsis

 

 

敗血症

Cellular Immunotherapy for Septic Shock

Ottawa Hospital Research Institute

 

ClinicalTrials.gov Identifier:

NCT03369275

 

13

Cardiovascular Diseases

 

心血管疾患

Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs

University Medical Center Utrecht Utrecht, Netherlands

 

ClinicalTrials.gov Identifier:

NCT03042572

 

14

Acute Kidney Tubular Necrosis

 

 

急性腎尿細管壊死

Effect of BM-MSCs in DCD Kidney Transplantation

The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

 

ClinicalTrials.gov Identifier: NCT02561767

 

15

Inflammatory Bowel Diseases

 

 

炎症性腸疾患

Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease

Children's National Medical Center Washington, District of Columbia, United States

 

ClinicalTrials.gov Identifier:

NCT02150551

 

16

Acute on Chronic Hepatic Failure

 

慢性肝不全で急性

 

Allogeneic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure

Hospital Clinic de Barcelona Barcelona, Spain

 

ClinicalTrials.gov Identifier: NCT02857010

 

17

Wilson's Disease

 

 

ウィルソン病

Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis

Department of Gastroenterology; Gulhane Military Medical Academy Ankara, Turkey

 

ClinicalTrials.gov Identifier:

NCT01378182

 

18

Degenerative Disc Disease

 

退行性椎間板病

Treatment of Degenerative Disc Disease With Allogeneic Mesenchymal Stem Cells (MSV)

Hospital Clinico Universitario Valladolid, Spain Instituto de Biologia y Genetica Molecular Valladolid, Spain

 

ClinicalTrials.gov Identifier: NCT01860417

 

19

Osteogenesis Imperfecta

 

 

骨形成

Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation

St. Jude Children's Research Hospital Memphis, Tennessee, United States

 

ClinicalTrials.gov Identifier:

NCT00705120

 

20

Aplastic Anemia

 

 

再生不良性貧血

Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo Ribeirão Preto, São Paulo, Brazil

 

ClinicalTrials.gov Identifier:

NCT01297972

 

21

Lumbar Spondylolisthesis Degenerative Discopathy

 

 

腰椎脊椎すべり症

Safety Study of Mesenchymal Stem Cells and Spinal Fusion

Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain Parc de Salut Mar Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain

 

ClinicalTrials.gov Identifier: NCT01552707

 

22

Type I Diabetes Mellitus With Ulcer

Type II Diabetes Mellitus With Ulcer

 

2型糖尿病

 

Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers

Orthopedic Rehabilitation out-patient clinic, Sheba Medical Center Ramat Gan, Israel

 

ClinicalTrials.gov Identifier: NCT01686139

 

23

Myocardial Infarction

 

心筋梗塞

A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction

National Research Medical Center Astana, Kazakhstan

 

ClinicalTrials.gov Identifier: NCT02672267

 

24

Non-Union Fracture Metaphyseal Fibrous Defect

非連合骨折下骨幹繊維欠損

 

Allogeneic Mesenchymal Stem Cell for Bone Defect or Non-Union Fracture (AMSC)

University of Indonesia Jakarta Pusat, Jakarta, Indonesia Faculty of Medicine, University of Indonesia Propinsi DKI Jakarta, Jakarta, Indonesia

 

ClinicalTrials.gov Identifier: NCT02307435

25

Neutropenic Enterocolitis Myeloablative Chemotherapy Induced Bone Marrow Aplasia

好中球減少腸炎

 

骨髄抑制化学療法による骨髄増殖症

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

 

State Research Center Burnasyan Federal Medical Biophysical Center FMBA of Russia Moscow, Russian Federation

 

ClinicalTrials.gov Identifier: NCT02145923

 

26

Diabetic Foot Ulcer

 

糖尿病性足部潰瘍

Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds

Steno Diabetes Center Copenhagen Gentofte, Denmark

 

ClinicalTrials.gov Identifier:

NCT03509870

 

27

Perinatal Arterial Ischemic Stroke Neonatal Stroke

 

周産期動脈虚血性脳卒中及び新生児ストローク

Perinatal Arterial Stroke Treated With Stromal Cells Intranasally

Wilhelmina Children's Hospital/University Medical Center Utrecht Utrecht, Netherlands

 

ClinicalTrials.gov Identifier:

NCT03356821

 

28

Hemophilia

 

血友病

Allogeneic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia

Military Medical Academy Cairo, Egypt

 

ClinicalTrials.gov Identifier:

NCT02108132

 

29

Buerger's Disease

 

閉塞性血栓性血管炎

A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buerger's Disease

Department of Surgical Disciplines, All India Institute of Medical Sciences New Delhi, Delhi, India

 

ClinicalTrials.gov Identifier:

NCT01484574

 

30

Bronchiectasis

 

 

気管支拡張症

Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non‐Cystic Fibrosis Bronchiectasis

University of Miami Hospitals & Clinics Miami, Florida, United States

 

ClinicalTrials.gov Identifier: NCT02625246

 

31

Primary Biliary Cirrhosis

 

原発性胆汁性肝硬変

Efficacy and Safety Study of Allogeneic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis (MSCsTreatPBC)

Peking Union Medical College Hospital Beijing, China

 

ClinicalTrials.gov Identifier: NCT01440309

 

32

Familial Hypercholesterolemia

 

 

家族性高コレステロール血症

Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia

Digestive Disease Research Center, Shariati Hospital, North Kargar Ave. Tehran, Iran, Islamic Republic of

 

ClinicalTrials.gov Identifier: NCT00515307

33

Lupus Nephritis

 

ループス腎炎

Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis

Hanyang University hospital Seoul, Korea, Republic of

 

ClinicalTrials.gov Identifier: NCT03174587

 

34

Non-Ischemic Heart Failure

 

 

非虚血性心不全

A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

MedStar Washington Hospital Center Washington, District of Columbia, United States

 

ClinicalTrials.gov Identifier:

NCT02467387

 

35

Asthma

 

喘息

Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma

University of Miami Miller School of Medicine Miami, Florida, United States

 

ClinicalTrials.gov Identifier: NCT03137199

 

36

Liver Cirrhosis

 

肝硬変

Allogeneic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis

Sun Yat-sen University Guangzhou, Guangdong, China

 

ClinicalTrials.gov Identifier: NCT01223664

 

37

Chronic Lung Allograft Dysfunction (CLAD)

 

慢性肺同種移植片機能不全

 

Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction

St Vincents Hospital Sydney, New South Wales, Australia

 

ClinicalTrials.gov Identifier: NCT02709343

 

38

Critical Limb Ischemia

重症肢虚血

Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease

Taipei Veterans General Taipei, Taiwan

 

ClinicalTrials.gov Identifier: NCT02336646

 

39

Diabetic Kidney Disease

 

糖尿病性腎疾患

NEPHSTROM for Diabetic Kidney Disease

National University of Ireland - Galway University Hospital -Regenerative Medicine Institute Galway, Ireland

 

ClinicalTrials.gov Identifier: NCT02585622

 

40

Cystic Fibrosis

 

嚢胞性線維症

Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis

University Hospitals Cleveland Medical Center Cleveland, Ohio, United States

 

ClinicalTrials.gov Identifier: NCT02866721

 

41

Osteoarthritis

 

変形性関節症

Treatment of Knee Osteoarthritis With Allogeneic Mesenchymal Stem Cells (MSV_allo)

Centro Medico Teknon Barcelona, Spain

 

ClinicalTrials.gov Identifier:

NCT01586312

42

Bone Cyst

 

骨嚢胞

Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation

Royan Institute Tehran, Iran, Islamic Republic of

 

ClinicalTrials.gov Identifier:

NCT01207193

 

43

Chemical Burn

 

化学燃焼

the Treatment of Human Bone Marrow Mesenchymal Stem Cells in Ocular Corneal Burn

Sun Yat-sen University Guangzhou, Guangdong, China

 

ClinicalTrials.gov Identifier:

NCT02325843

 

44

Autoimmune Disease

 

 

自己免疫疾患

Allogeneic Human Mesenchymal Stem Cells (hMSC) in Patients With Fistulizing Crohn's Disease Via Peri fistula injections (GALENE)

University of Miami Miller School of Medicine Miami, Florida, United States

 

ClinicalTrials.gov Identifier: NCT02677350

 

45

Retinitis Pigmentosa

 

網膜色素変性症

Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa

Siriraj Hospital Mahidol University Bangkoknoi, Bangkok, Thailand

 

ClinicalTrials.gov Identifier:

NCT01531348

 

46

Amyotrophic Lateral Sclerosis

 

 

筋萎縮性側索硬化症

Intravenous Transplantation of Mesenchymal Stem Cell in Patients With ALS

Royan Institute Tehran, Iran, Islamic Republic of

 

ClinicalTrials.gov Identifier: NCT01759797

 

47

Cardiomyopathy

 

心筋症

Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines

M D Anderson Cancer Center Houston, Texas, United States

 

ClinicalTrials.gov Identifier:

NCT02408432

 

48

Rheumatoid Arthritis

 

関節リウマチ

Transplantation of Bone Marrow Derived Mesenchymal Stem Cells in Affected Knee Osteoarthritis by Rheumatoid Arthritis

Royan Institute Tehran, Iran, Islamic Republic of

 

ClinicalTrials.gov Identifier:

NCT01873625

 

49

Prostate Cancer

 

 

前立腺がん

Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer (MSC)

Johns Hopkins Hospital Baltimore, Maryland, United States

 

ClinicalTrials.gov Identifier:

NCT01983709

 

50

Kleinfelter Syndrome

 

クリンフェルター症候群

 

Sperm Production in Kleinfelter Syndrome Patients After Mesenchymal Stem Cell Injection

Man Clinic for Andrology and male infertility Cairo, Egypt

 

ClinicalTrials.gov Identifier:

NCT02414295

 

 

51

Osteochondral Defects

The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects

Department of Orthopedic Surgery and Tissue Culture Unit of the Department of Medical Biochemistry - Cairo University School of Medicine - Kasr Al Ainy Hospitals -Al-Saray Street, El Manial Cairo, Egypt

 

ClinicalTrials.gov Identifier: NCT00891501

52

Ischemic Heart Disease

Sequential Treatment of Extra-Corporeal Shock Wave Combined With autologous Bone marrow Mesenchymal Stem Cells on Patients With ischemic Heart Disease: the S-CURE Study

Shanghai Tenth People's Hospital, Tongji University Shanghai, Shanghai, China

 

ClinicalTrials.gov Identifier: NCT03397095

53

Chronic Periodontitis

Autologous Alveolar Bone Marrow Mesenchymal Stem Cells for the Reconstruction of Infrabony Periodontal Defects

Dental School, Aristotle University Thessaloniki, Greece

 

ClinicalTrials.gov Identifier: NCT02449005

54

Chronic Kidney Disease

Autologous Bone Marrow Derived Mesenchymal Stromal Cells (BM-MSCs) in Patients With Chronic Kidney Disease (CKD)

Royan Institute Tehran, Iran, Islamic Republic of

 

ClinicalTrials.gov Identifier: NCT02195323

55

Idiopathic Pulmonary Hemosiderosis

Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis

Weiping Tan, Sun Yat-sen University

 

ClinicalTrials.gov Identifier: NCT02985346

56

Spinal Cord Injury

Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries

Hospital Puerta de Hierro Majadahonda, Madrid, Spain

 

ClinicalTrials.gov Identifier: NCT02570932

57

Multiple Sclerosis

Safety and Efficacy Study of Autologous Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis

Cell Therapy Center, Jordan University Hospital, Amman, Jordan

 

ClinicalTrials.gov Identifier: NCT01895439

58

Avascular Necrosis of Femur Head

Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head

Hospital Universitari Vall d'Hebron Barcelona, Spain

 

ClinicalTrials.gov Identifier: NCT01605383

59

Diabetic Foot

Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer

the southwest Hospital Chongqing, Chongqing, China

 

ClinicalTrials.gov Identifier: NCT00955669

60

Erectile Dysfunction

Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED)

University of Jordan

 

ClinicalTrials.gov Identifier:

NCT02945462

 

 

61

Limbus Corneae Insufficiency Syndrome

Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome

IOBA Valladolid, Spain

 

ClinicalTrials.gov Identifier: NCT01562002

62

Non Healing Wounds

Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds

Roger Williams Medical Center Providence, Rhode Island, United States

 

ClinicalTrials.gov Identifier: NCT01751282

63

Anoxic Brain Injury

Safety and Efficacy Assessment of Autologous Bone-marrow Derived Adult Mesenchymal Stem Cell Therapy in Patients With Anoxic(or Hypoxic) Brain Injury Pilot Trial

Hanyang University Hospital Seoul, Korea, Republic of

 

ClinicalTrials.gov Identifier: NCT02210624

64

Relapsing Remitting Multiple Sclerosis (RRMS)

Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis

Germans Trias i Pujol Hospital Badalona, Barcelona, Spain

 

ClinicalTrials.gov Identifier: NCT02035514

65

Chronic Myocardial Ischemia

Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device

Cardiology Department of Rangueil Hospital - Rangueil Hospital Toulouse, France

 

ClinicalTrials.gov Identifier: NCT02460770

66

Asherman Syndrome

Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures

D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology Saint Petersburg, Russian Federation

 

ClinicalTrials.gov Identifier: NCT03166189

67

Severe Aplastic Anemia

Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.

Guangzhou General Hospital of Guangzhou Military Command Guangzhou, Guangdong, China

 

ClinicalTrials.gov Identifier: NCT02247973

68

Tibia or Femur Pseudo-arthrosis

Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow

University Hospital, Clermont-Ferrand

 

ClinicalTrials.gov Identifier: NCT00557635

69

Age Related Macular Degeneration

Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration

Al-Azhar university medical school (Benin-cairo) ophthalmology department Cairo, Nasr city, Egypt

 

ClinicalTrials.gov Identifier: NCT02016508

70

Intervertebral Disc Disease

Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease

Trauma Service. Hospital Universitario de Salamanca Salamanca, Castilla-León, Spain

 

ClinicalTrials.gov Identifier: NCT01513694

 

71

Emphysema

Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients

Masih-Daneshvari Hospital Tehran, Iran, Islamic Republic of

 

ClinicalTrials.gov Identifier: NCT01758055

72

Hip Osteoarthritis

Mesenchymal Stem Cell Transplantation in Osteoarthritis of Hip Joint

Royan Institute Tehran, Iran, Islamic Republic of

 

ClinicalTrials.gov Identifier: NCT01499056

73

Alcoholic Liver Cirrhosis

The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis

Yonsei University Wonju College of Medicine Wonju Christian Hospital Wonju, Kangwon-do, Korea, Republic of

 

ClinicalTrials.gov Identifier: NCT01741090

74

Nonunion Fractures

Allogeneic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture (AMSC)

Ismail Hadisoebroto Dilogo, Indonesia University

 

ClinicalTrials.gov Identifier: NCT02307435

75

Disc Degeneration

Mesenchymal Stem Cells for Lumbar Degenerative Disc Disease

University Hospitals Cleveland Medical Center Cleveland, Ohio, United States

 

ClinicalTrials.gov Identifier: NCT03692221

76

Retinal Degeneration

Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.

Ribeirão Preto Medical School Ribeirao Preto, Sao Paulo, Brazil

 

ClinicalTrials.gov Identifier: NCT02330978

77

Avascular Necrosis of the Femoral Head

Evaluation of Mesenchymal Stem Cells to Treat Avascular Necrosis of the Hip

Department of Orthopaedic Surgery, Hôpital Henri Mondor Créteil, France

 

ClinicalTrials.gov Identifier: NCT02065167

78

Spondylitis

A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis

Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

 

ClinicalTrials.gov Identifier: NCT02809781

 

79

Relapsing-Remitting Multiple Sclerosis

Autologous Mesenchymal Stromal Cells for Multiple Sclerosis

Hospital Vall Hebron Barcelona, Spain

 

ClinicalTrials.gov Identifier: NCT02495766

80

Cerebral Palsy

Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy

Stem Cells Arabia

 

ClinicalTrials.gov Identifier: NCT03078621

 

 

81

Progressive Supranuclear Palsy

Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism

ICP Parkinson Institute Milano, Italy

 

ClinicalTrials.gov Identifier: NCT01824121

82

Chronic Pancreatitis

Mesenchymal Stem Cell and Islet Co-transplantation

GI Surgery, Medical University of South Carolina Charleston, South Carolina, United States

 

83ClinicalTrials.gov Identifier: NCT02384018

83

Urinary Incontinence

Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence

Maternity hospital, Ain Shams University Cairo, Egypt

 

ClinicalTrials.gov Identifier: NCT02334878

84

Osteoarthritis Post-meniscectomy

Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy

Rush University Medical Center Chicago, Illinois, United States

 

ClinicalTrials.gov Identifier: NCT02582489

85

Male Infertility

MSCs For Treatment of Azoospermic Patients

Al Azhar University , School of Medicine Nasr City, Cairo, Egypt

 

ClinicalTrials.gov Identifier: NCT02025270

86

Ischemic Stroke

A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke

University of California, San Diego

 

ClinicalTrials.gov Identifier: NCT01297413

87

Pulmonary Emphysema

Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema

Federal Research Clinical Center of Federal Medical and Biological Agency of Russia, Moscow, Moscow Region, Russian Federation

 

ClinicalTrials.gov Identifier: NCT01849159

88

ST Segment Elevation Myocardial Infarction (STEMI)

A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI)

Stemedica Cell Technologies, Inc.

 

ClinicalTrials.gov Identifier: NCT01770613

89

Articular Cartilage Disorder of Knee

Mesenchymal Stem Cells in Knee Cartilage Injuries

Cell Therapy Center, Jordan University Hospital, Amman, Jordan

 

ClinicalTrials.gov Identifier: NCT02118519

90

Dermatologic Disorders

Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging

Naval Medical Center San Diego San Diego, California, United States

 

ClinicalTrials.gov Identifier: NCT01771679

 

91

Chronic Disease

Mesenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair

Hospital Universitario Clinico San Carlos Madrid, Spain

 

ClinicalTrials.gov Identifier: NCT01687777

92

Angioplasty

Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients

Yuejin Yang, Chinese Academy of Medical Sciences, Fuwai Hospital

 

ClinicalTrials.gov Identifier: NCT03047772

93

Rotator Cuff Tear

Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions

Petr Šmíd Znojmo, Czech Republic, Czechia

 

ClinicalTrials.gov Identifier:

NCT03068988

94

Middle Cerebral Artery Infarction

Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct

UKM Medical Centre Kuala Lumpur, Malaysia

 

ClinicalTrials.gov Identifier:

NCT01461720

95

Premature Ovarian Failure

Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure

Al-Azhar University hospitals and Al Azhar Regenerative Medicine International Center (ARMIC) Cairo, Egypt

 

ClinicalTrials.gov Identifier: NCT02062931

96

Ischemic Heart Disease Non-ischemic Cardiomyopathy

Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device

Medstar Health Research Institute

 

ClinicalTrials.gov Identifier: NCT03925324

97

Scleroderma

Treatment of Refractory Severe Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells

Saint-Louis Hospital Paris, France

 

ClinicalTrials.gov Identifier:

NCT02213705

98

Cerebrovascular Disorders

Allogeneic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke

Leila Dehghani, Isfahan University of Medical Sciences

 

ClinicalTrials.gov Identifier: NCT03384433

99

Facetogenic Back Pain

Allogeneic Human Mesenchymal Stem Cell Injection in Patients with FaceTogenic Back Pain

ISCI / University of Miami Miller School of Medicine Miami, Florida, United States

 

ClinicalTrials.gov Identifier:

NCT03487731

100

Aging Frailty

Allogeneic Human Mesenchymal Stem Cells (hMSC) in Patients With Aging Frailty Via Intravenous Delivery.

ISCI/University of Miami Miller School of Medicine Miami, Florida, United States

 

ClinicalTrials.gov Identifier: NCT02065245

     

Would like to see how the procedure looks like?
  

    
In this video below, Dr. Igor Miliaiev, the regional deputy director of medicine in Kintaro Cells Power Corporation, demonstrates and explains the whole process of cell administration.

Kintaro Stem Cells® use mesenchymal stem cells from bone marrow, extracted from vetted healthy donors. Live cells are cultivated in our laboratories and injected fresh in the recipients within 48 hours of harvesting.

How Kintaro Stem Cells® work in the body?

Kintaro Stem Cells® have a pathotropic effect, travelling straight to the damaged organs and tissues and repairing them. Their ability to produce a different system’s stem cells and differentiate into cells of different adult tissues (e.g. bones, cartilage, adipose tissue, muscle) makes Kintaro Stem Cells® the right choice of cells for renewing your body.

The three methods of administering Kintaro Stem Cells® treatment are the intravenous method, local administration and exterior application of Kintaro Enriched Medium on the face and body. While these are various methods of treatments, the best results as observed over the 1200 stem cell treatments provided to patients in Southeast Asia is derived from the combination of all three methods of administration.
  
One of the choices you can now make to possibly improve your health is undergo treatment with the Kintaro Stem Cells® / KINTARO Cells® Japan VIP Rejuvenation Program. Consult with us on for a detailed program for your specific needs and medical attention.

BOOK AN ONLINE CONSULTATION NOW:

Contact form